RecruitingNot ApplicableNCT05216666

The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty

Abductor Insufficiency After Total Hip Arthroplasty; Risk Factors and Diagnosis


Sponsor

Sahlgrenska University Hospital

Enrollment

580 participants

Start Date

May 11, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Residual limping after total hip arthroplasty is empirically associated with the use of lateral approach but has been reported in litterature even with the use of posterior approach. The purpose of this clinical trial is to compare the risk of residual limping one year after total hip arthropasty between lateral and posterior approach.


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Lateral approach and a procedure called Posterior approach for people with arthroplasty complications, muscle atrophy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELateral approach

Total hip arthroplasty performed through a lateral surgical approach (Gammer)

PROCEDUREPosterior approach

Total hip arthroplasty performed through a posterior surgical approach (Moore)


Locations(1)

Sahlgrenska University Hospital

Mölndal, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05216666


Related Trials